22.418 articles found

The efficacy of combined estrogen and buspirone treatment in olivopontocerebellar atrophy.

Heo JH, Lee ST, Chu K, Kim M.

J Neurol Sci · 2008-05-07

DOI: 10.1016/j.jns.2008.03.016PMID: 18466925

Treatment with low doses of cabergoline is not associated with increased prevalence of cardiac valve regurgitation in patients with hyperprolactinaemia.

Bogazzi F, Buralli S, Manetti L, Raffaelli V, Cigni T, Lombardi M, Boresi F, Taddei S, Salvetti A, Martino E.

Int J Clin Pract · 2008-05-06

DOI: 10.1111/j.1742-1241.2008.01779.xPMID: 18462372

Leptin neuroprotection in the CNS: mechanisms and therapeutic potentials.

Signore AP, Zhang F, Weng Z, Gao Y, Chen J.

J Neurochem · 2008-05-03

DOI: 10.1111/j.1471-4159.2008.05457.xPMID: 18466320

TREATMENT OF SYNUCLEINOPATHIES

LANSBURY PETER T. JR, JUSTMAN CRAIG J.

· 2008-05-02

NEW PYRIMIDINE DERIVATIVES AND THEIR USE IN THERAPY AS WELL AS THE USE OF PYRIMIDINE DERIVATIVES IN THE MANUFACTURE OF A MEDICAMENT FOR PRVENTION AND/OR TREATMENT OF ALZHEIMER'S DISEASE

ANDERSSON LARS, ARZEL ERWAN, BERG STEFAN, BURROWS JEREMY, HELLBERG SVEN, HUERTA FERNANDO, PEDERSEN TORBEN, REIN TOBIAS, ROTTICCI DIDIER, STAAF KARIN, TUREK DOMINIKA.

· 2008-05-02

The course of dyskinesia induction by different treatment schedules of levodopa in Parkinsonian rats: is continuous dopaminergic stimulation necessary?

Tsironis C, Marselos M, Evangelou A, Konitsiotis S.

Mov Disord · 2008-05-01

DOI: 10.1002/mds.21630PMID: 18442128

Potential therapeutic role of statins in neurological disorders.

Bifulco M, Malfitano AM, Marasco G.

Expert Rev Neurother · 2008-05-01

DOI: 10.1586/14737175.8.5.827PMID: 18457539

Stem cells and Parkinson's disease: toward a treatment, not a cure.

Svendsen C.

Cell Stem Cell · 2008-05-01

DOI: 10.1016/j.stem.2008.04.010PMID: 18462691

[The status of imaging methods for the treatment of patients with Parkinson's syndrome].

Schwarz J, Gratz S, Hahn U, Förstl H, Jarnig M.

Dtsch Med Wochenschr · 2008-05-01

DOI: 10.1055/s-2008-1075679PMID: 18437640

Potassium channels in the basal ganglia: promising new targets for the treatment of Parkinson's disease.

Wang G, Zeng J, Ren R, Chen S.

Front Biosci · 2008-05-01

DOI: 10.2741/2959PMID: 18508465

Potassium channels in the basal ganglia: promising new targets for the treatment of Parkinson's disease.

Wang G, Zeng J, Ren R, Chen S.

Front Biosci · 2008-05-01

DOI: 10.2741/2971PMID: 18508477

Catechol-O-methyltransferase inhibition improves levodopa-associated strength increase in patients with Parkinson disease.

Müller T, Kolf K, Ander L, Woitalla D, Muhlack S.

Clin Neuropharmacol · 2008-05-01

DOI: 10.1097/wnf.0b013e31811510edPMID: 18520980